191 related articles for article (PubMed ID: 9890139)
1. Modified hemoglobin blood substitutes: present status and future perspectives.
Chang TM
Biotechnol Annu Rev; 1998; 4():75-112. PubMed ID: 9890139
[TBL] [Abstract][Full Text] [Related]
2. [Development and challenge of modified hemoglobins as red blood cell substitutes].
Lu XL
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
[TBL] [Abstract][Full Text] [Related]
3. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
Chang TM
Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
[TBL] [Abstract][Full Text] [Related]
4. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
Smani Y; Labrude P; Vigneron C; Faivre B
Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
[TBL] [Abstract][Full Text] [Related]
5. Future prospects for artificial blood.
Chang TM
Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell substitutes: microencapsulated hemoglobin and cross-linked hemoglobin including pyridoxylated polyhemoglobin & conjugated hemoglobin.
Chang TM
Biomater Artif Cells Artif Organs; 1988; 16(1-3):11-29. PubMed ID: 3052638
[No Abstract] [Full Text] [Related]
7. Red cell substitutes from hemoglobin--do we start all over again?
Kluger R
Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell substitutes.
Chang TM
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):651-67. PubMed ID: 11102282
[TBL] [Abstract][Full Text] [Related]
9. Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):1-24. PubMed ID: 9083622
[No Abstract] [Full Text] [Related]
10. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
Bian YZ; Guo C; Chang TM
Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265
[TBL] [Abstract][Full Text] [Related]
11. Chemically modified and recombinant hemoglobin blood substitutes.
Snyder SR; Walder JA
Biotechnology; 1991; 19():101-16. PubMed ID: 1786467
[TBL] [Abstract][Full Text] [Related]
12. Blood substitutes. Haemoglobin therapeutics in clinical practice.
Baron JF
Crit Care; 1999; 3(5):R99-102. PubMed ID: 11094489
[TBL] [Abstract][Full Text] [Related]
13. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
Chang TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):418-30. PubMed ID: 20564467
[TBL] [Abstract][Full Text] [Related]
14. Future generations of red blood cell substitutes.
Chang TM
J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
[TBL] [Abstract][Full Text] [Related]
15. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
[TBL] [Abstract][Full Text] [Related]
16. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents.
Osawa Y; Darbyshire JF; Meyer CA; Alayash AI
Biochem Pharmacol; 1993 Dec; 46(12):2299-305. PubMed ID: 8274164
[TBL] [Abstract][Full Text] [Related]
17. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.
Guo C; Chang TMS
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1349-1363. PubMed ID: 29873524
[TBL] [Abstract][Full Text] [Related]
18. Blood substitutes based on modified hemoglobin.
Bakker JC; Bleeker WK
Vox Sang; 1994; 67 Suppl 3():139-42. PubMed ID: 7975479
[No Abstract] [Full Text] [Related]
19. [Red cell substitutes: perfluorocarbon emulsions and hemoglobin solutions].
Rémy B; Deby-Dupont G; D'Ans V; Ernest P; Lamy M
Ann Fr Anesth Reanim; 1999 Feb; 18(2):211-24. PubMed ID: 10207594
[TBL] [Abstract][Full Text] [Related]
20. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
Chang TM
Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
